The CRISPR Revolution: What Editing Human DNA Reveals About the Patent System\u27s DNA by Feldman, Robin
University of California, Hastings College of the Law
UC Hastings Scholarship Repository
Faculty Scholarship
2016
The CRISPR Revolution: What Editing Human
DNA Reveals About the Patent System's DNA
Robin Feldman
UC Hastings College of the Law, feldmanr@uchastings.edu
Follow this and additional works at: https://repository.uchastings.edu/faculty_scholarship
This Article is brought to you for free and open access by UC Hastings Scholarship Repository. It has been accepted for inclusion in Faculty Scholarship
by an authorized administrator of UC Hastings Scholarship Repository. For more information, please contact wangangela@uchastings.edu.
Recommended Citation
Robin Feldman, The CRISPR Revolution: What Editing Human DNA Reveals About the Patent System's DNA, 64 UCLA L. Rev. Disc. 392
(2016).
Available at: https://repository.uchastings.edu/faculty_scholarship/1552
The CRISPR Revolution: What Editing
Human DNA Reveals About the
Patent System’s DNA 
Robin Feldman
ABSTRACT
Not since the invention that launched the entire biotech industry has a life science 
invention offered as much promise as the CRISPR technique for editing genes.  Gene 
editing techniques existed before CRISPR, but they were slow, inaccurate, and expensive. 
The CRISPR invention is like moving from the manual typewriter—click, clack, slide 
across—to modern word processing.
As we stand at this remarkable threshold, what of the patent system?  The CRISPR 
story defies traditional patent theory.  Companies are racing to develop commercial 
applications for the technology and researchers are using the technology, even though 
it is not clear how or if they will obtain a license for it.  Commercialization is moving 
forward, and not on the patent system’s timeline.
Perhaps CRISPR is the exception that proves the rule.  After all, great leaps forward may 
never fit the day-to-day regime.  But do we really want a patent system that works only 
for mediocrity?  Shouldn’t the patent system be designed for the truly great?  This Article 
suggests that perhaps we should be willing to move slightly away from the winner-
take-all orientation of the patent system, recognizing that some aspects of compulsory 
licensing may better reflect the patent system as it operates on the ground.  At the very 
least, we should focus on the ways in which the lumbering patent system fails to match 
the speed and the dictates of science and innovation.  Just as CRISPR allows editing 
of human DNA, how can we edit the patent system’s DNA so that it performs to its 
greatest potential.
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AUTHOR
Harry & Lillian Hastings Professor and Director of the Institute for Innovation Law, 
University of California Hastings College of the Law.  The Institute’s Startup Legal 
Garage program matches early stage companies with students and supervising attorneys 
at outside law firms for free legal work.  Caribou, which was founded by the University of 
California’s clustered regularly-interspaced short palindromic repeats (CRISPR) inventor 
group, was matched by the program in the company’s early stages.  The Institute receives 
no privileged or confidential information, but reading about the company spurred the 
author’s interest in the science of CRISPR and its implications for the patent system. 
The author also notes the general affiliation of the University of California Hastings and 
the broader University of California system.  I am grateful to Evan Frondorf and Connie 
Wang for invaluable research assistance and to Shelley Ackerman and Nathan Kipniss 
for comments on prior drafts.  I also wish to thank participants in the UCLA Program 
on Understanding Law, Science, and Evidence (PULSE) Symposium on “Imagining the 
Legal Landscape: Technology and the Law in 2030” for their comments and reflections.
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